Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs - A multi-centre, randomized-controlled trial

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Scherbaum, Werner A ^a,b   Ohmann, Christian ^a   Abholz, Heinz Harald ^a   Dragano, Nico ^a   Lankisch, Mark ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIQUIDONE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG SAFETY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; HYPEROSMOLAR COMA; HYPOGLYCEMIA; HYPOGLYCEMIC SHOCK; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; SHOCK; BLOOD; METABOLISM; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 52649144366     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003087     Document Type: Article

References (20)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
2. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, et al. (2001) Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 111: 1-9.
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
4. Owens DR, Barnett AH, Pickup JC, Kerr D, Bushby P, et al. (2004) Blood glucose monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes and Primary Care 6: 8-16.
5. Bergenstal RM, Gavin JR III (2005) The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 118: 1S-6S.
6. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, et al. (2006) Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29: 1963-1972.
7. Davis WA, Bruce DG, Davis TM (2006) Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care 29: 1764-1770.
8. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878-1886.
9. Farmer A, Wade A, Goyder E, Yudkin P, French D, et al. (2007) Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 335: 132-139.
10. Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research. Oxford: Blackwell Science.
11. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, et al. (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49: 271-278.
12. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, et al. (2005) Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28: 1510-1517.
13. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, et al. (1989) Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab 15: 255-260.
14. Muchmore DB, Springer J, Miller M (1994) Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 31: 215-219.
15. Allen BT, DeLong ER, Feussner JR (1990) Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 13: 1044-1050.
16. Schwedes U, Siebolds M, Mertes G (2002) Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 25: 1928-1932.
17. Davidson MB, Castellanos M, Kain D, Duran P (2005) The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 118: 422-425.
18. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, et al. (2003) Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 29: 587-594.
19. Koster I, von FL, Ihle P, Schubert I, Hauner H (2006) The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM study. Diabetologia 49: 1498-1504.
20. Soumerai SB, Mah C, Zhang F, Adams A, Barton M, et al. (2004) Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med 164: 645-652.